Life Sci News Today

Most life scientists would agree that understanding how cellular processes work requires structural knowledge about the macromolecules involved. For example, deciphering the double-helical nature of DNA revealed essential aspects of how genetic information is stored, copied and repaired. Yet, being reductionist in nature, structural biology requires the purification of large amounts of macromolecules, often trimmed off larger functional units. The advent of cryogenic electron microscopy...

Personalised vaccines used to prevent cancer coming back after surgery will be available on the NHS within five years, according to the national director of cancer.Professor Peter Johnson described the last decade of cancer immunotherapy research as an “explosion of knowledge” that has allowed the c

£16m private funding will be matched by UK Government.

Former CEO and Chairman of Google Eric Schmidt, and Ken Griffin, founder and CEO of Citadel and founder of Griffin Catalyst, are today (Monday 30 October) being announced as the first members of a new consortium that will shape the future of the best-in-class UK Biobank, starting with £16 million funding matched by government.

Postdoctoral fellow in cell biology job in Malmö (Stad), Skåne (SE) with Lund University . Apply Today.

Prolonged hospital stays carry risks like higher mortality, readmission chances and physical decline, especially in the elderly, prompting ACE and the NHS AI Lab to pioneer an AI tool to identify

The emergence of natural selection, requiring that reproducing entities present variations that may be inherited and passed on, was arguably the most important breakthrough in the self-organization of life. In this Perspective, the assumptions governing biological reproduction are confronted with physico-chemical principles that control the evolution of material systems. In biology, the reproduction of living organisms is never considered to be reversible, whereas microscopic reversibility is an...

Seventeen new projects will receive funding for cutting edge medicine manufacturing, delivered by the Innovate UK Transforming Medicine Manufacturing programme. Today, Innovate UK, the UK’s innovation agency, is pleased to announce the winners of a series of competitions focusing on: nucleic acid medicines manufacturing intracellular drug delivery digitalisation and automation Addressing different challenges The projects span across the country to address different challenges.

The money will support 17 projects across three fields.

Integrated drug formulation and clinical trials company, BDD Pharma, will be expanding its phase appropriate development, manufacturing, and clinical testing services after a £2 million ($1.3 million) investment.